HUNTINGTON INGALLS INDUSTRIES, INC. (NYSE: HII) awarded Hughes Edmond E. Jr. 11 derivative securities on Sep. 11, 2026. Edmond is the former vice president and chief human resources officer of Huntington Ingalls Industries.
HUNTINGTON INGALLS INDUSTRIES, INC. (NYSE: HII) awarded director Jimenez Frank R 17 shares at $0 per share on 11 September 2026. The transaction was recorded under code A.
Elicio Therapeutics, Inc. (NASDAQ: ELTX) has set November 12, 2026, for its annual meeting of stockholders. The company will provide the meeting’s exact time, location and voting matters in its proxy statement.
● Nakamoto, formerly KindlyMD, ended its healthcare clinic operations on June 19, 2026 and now operates as aBitcointreasury holding roughly 4,467 Bitcoin valued at about $261.5 million as of the second quarter of 2026.
Emergent BioSolutions Inc. (NYSE: EBS) Chief Executive Joseph C. Papa presented the company’s investor slides at the H.C. Wainwright GlobalInvestmentConference on September 14. The material set out management’s public-health focus and operating priorities.
● Nutex Health swung to second-quarter 2026Net Incomeof $65.8 million and diluted EPS of $9.38, from a $17.7 million loss a year earlier, even asRevenuefell 13.6% to $210.8 million after a HaloMD billing-partner amendment and lower federal arbitration fees.
EnVVeno Medical Corp (NASDAQ: NVNO) director Duhay Francis sold 11 shares at $11.21 per share on 11 September 2026. Following the transaction, Francis owned 2,351 shares of enVVeno Medical Corp.
Guardant Health, Inc. (NASDAQ: GH) director Azar Alex M II exercised options for 1,651 shares at $0 per share on 12 September 2026.
TheNasdaqComposite is broad enough to hold almost every Nasdaq-listed common stock, which means it also holds the small and mid-cap biotech names where the market's real drug-development risk lives. uniQure (NASDAQ:QURE), Xencor (NASDAQ:XNCR), Rani Therapeutics (NASDAQ:RANI), Pyxis Oncology (NASDAQ:PYXS) and Precision BioSciences (NASDAQ:DTIL) span …
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) executive Patil Neena M sold 1,200 shares at $240.94 per share on 10 September 2026, leaving her with 47,671 shares. The transaction represented about 2.5% of her prior shares holding.